These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1033 related items for PubMed ID: 3527658

  • 1. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP, Campoli-Richards DM.
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [Abstract] [Full Text] [Related]

  • 2. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE, Jensen RT, Gardner JD.
    Annu Rev Med; 1986 Jul; 37():97-105. PubMed ID: 3010811
    [Abstract] [Full Text] [Related]

  • 3. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 4. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB.
    Scand J Gastroenterol Suppl; 1986 Aug; 118():123-8. PubMed ID: 3460167
    [Abstract] [Full Text] [Related]

  • 5. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 Aug; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 6. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM, Clissold SP.
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [Abstract] [Full Text] [Related]

  • 7. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
    Lambers CB, Lind T, Moberg S, Jansen JB, Olbe L.
    N Engl J Med; 1984 Mar 22; 310(12):758-61. PubMed ID: 6142418
    [Abstract] [Full Text] [Related]

  • 8. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM, Faulds D.
    Drugs; 1994 Sep 22; 48(3):404-30. PubMed ID: 7527761
    [Abstract] [Full Text] [Related]

  • 9. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Oct 22; 58(4):725-42. PubMed ID: 10551440
    [Abstract] [Full Text] [Related]

  • 10. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 Oct 22; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 11. Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.
    Langtry HD, Wilde MI.
    Drugs; 1997 Sep 22; 54(3):473-500. PubMed ID: 9279507
    [Abstract] [Full Text] [Related]

  • 12. Omeprazole: a comprehensive review.
    Massoomi F, Savage J, Destache CJ.
    Pharmacotherapy; 1993 Sep 22; 13(1):46-59. PubMed ID: 8437967
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI, Mohnen J, Shaw S.
    Aliment Pharmacol Ther; 1996 Aug 22; 10(4):497-506. PubMed ID: 8853753
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI, Goa KL.
    Drugs; 2001 Aug 22; 61(15):2327-56. PubMed ID: 11772142
    [Abstract] [Full Text] [Related]

  • 15. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA.
    Expert Opin Pharmacother; 2001 Oct 22; 2(10):1663-70. PubMed ID: 11825309
    [Abstract] [Full Text] [Related]

  • 16. [Omeprazole in the therapy of acid-induced diseases].
    Simon B, Dammann HG, Müller P.
    Z Gastroenterol; 1987 Aug 22; 25 Suppl 3():146-51. PubMed ID: 2889299
    [Abstract] [Full Text] [Related]

  • 17. Omeprazole: a new drug for the treatment of acid-peptic diseases.
    Falk GW.
    Cleve Clin J Med; 1991 Aug 22; 58(5):418-27. PubMed ID: 1934456
    [Abstract] [Full Text] [Related]

  • 18. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Aug 22; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 19. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M, Alcabes G, Lehy T, Nguyen Phuoc BK, Vatier J, Bonfils S.
    Gastroenterol Clin Biol; 1984 Dec 22; 8(12):947-54. PubMed ID: 6519403
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC, Soule JC, Mignon M, Goldfain D, Cortot A, Travers B, Isal JP, Bader JP.
    Dig Dis Sci; 1986 Jul 22; 31(7):693-9. PubMed ID: 2873001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.